Chris Storgard, Chief Medical Officer at FATE THERAPEUTICS INC (FATE), bought 75,186 shares at $2.66 ($200K) on 2016-11-23, disclosed to the SEC on 2016-11-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.66 | 37,593 | $100K | 50.0% |
| 2 | $2.66 | 37,593 | $100K | 50.0% |
| Total | $2.66 avg | 75,186 | $200K | 100% |